If a novel topical medication significantly disrupts keratin filament cross-linking within the stratum corneum, which consequence is most likely?

💡 Explanation

Disrupting keratin cross-linking weakens the skin's structural integrity because the stratum corneum relies on these linkages for barrier function. Therefore, barrier function is compromised, rather than melanocyte, sebum, or collagen alterations, because these depend on separate physiological processes.

• Why does immobilization of a fractured tibia lead to increased bone resorption around the fracture site, impacting the remodeling process?
• Why does taking non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen reduce fever in a patient with a viral infection?
• Why does repeated administration of synthetic GnRH agonists, intended to stimulate ovulation, paradoxically inhibit reproductive function?
• What causes rapid spread of antibiotic resistance when bacteria exchange plasmids?
• If a patient exhibits inflammation due to an overactive NF-κB pathway secondary to chronic TNF-α signaling in intestinal epithelial cells, which intervention targets the core problem?
• If a growth factor receptor on a cancer cell acquires a mutation preventing cyclin-dependent kinase (CDK) inhibition despite checkpoint activation, which consequence follows?